Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.

about

Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.

Item

http://www.wikidata.org/entity/Q47855866

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Liver transplantation from a d ...... ontraindicated: A case report.

@en

Liver transplantation from a d ...... ontraindicated: A case report.

@nl

type

Item

label

Liver transplantation from a d ...... ontraindicated: A case report.

@en

Liver transplantation from a d ...... ontraindicated: A case report.

@nl

prefLabel

Liver transplantation from a d ...... ontraindicated: A case report.

@en

Liver transplantation from a d ...... ontraindicated: A case report.

@nl

P1476

Liver transplantation from a d ...... ontraindicated: A case report.

@en

P2093

Aysel Yuce

http://www.w3.org/2001/XMLSchema#string

Cahit Tanyel

http://www.w3.org/2001/XMLSchema#string

Fatma Gumruk

http://www.w3.org/2001/XMLSchema#string

Osman Abbasoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect.

Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ.

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients

Is serum hepcidin causative in hemochromatosis? Novel analysis from a liver transplant with hemochromatosis.

The marginal liver donor--an update.

Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens.

Challenges to liver transplantation and strategies to improve outcomes.

Current developments in pediatric liver transplantation

Strategies to optimize the use of marginal donors in liver transplantation.

P31

scholarly article

P356

10.1111/PETR.12903

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Ozen

Ersin Gumus

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28211259

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation